Tag: CABG

Hackensack Meridian Health Seeks Disruptive Health Solutions through NJ Innovation Challenge

sarah JonasAnnouncement

The Challenge seeks to reduce 30-day readmissions for: acute myocardial infarction (AMI); chronic obstructive pulmonary disease (COPD); heart failure (HF); pneumonia; coronary artery bypass graft (CABG) surgery; and elective primary total hip arthroplasty and/or total knee arthroplasty (THA/TKA).

Novel Surgical Device Can Potentially Improve Outcomes of Coronary Bypass Grafting That Uses Leg Veins

sarah JonasResearch Alert

(New York, NY – November 13, 2021) –A novel device called venous external support (VEST) may lead to increased longevity and durability of saphenous (leg) vein grafting during coronary artery bypass surgery, according to a new trial done in collaboration…

New Research Supports Initial Conservative Management of Stable Coronary Artery Disease

sarah JonasFeature

New study results confirm that guideline-directed medical therapy is as effective as more invasive procedures at preventing death, stroke, and heart attack in patients with stable coronary artery disease (CAD).

The study results suggest that guideline-directed medical therapy should be the initial treatment strategy for patients with stable CAD.

The study results validate the evidence-based, guideline-directed, conservative treatment approach that the cardiovascular specialists at Nuvance Health have always used to treat CAD.

Michigan hospital improves post-CABG outcomes, using proactive amiodarone protocol

sarah JonasResearch Results

A quality improvement project at Beaumont Hospital in Michigan resulted in a decreased incidence of postoperative atrial fibrillation and shorter mean lengths of stay. The results indicate that an amiodarone POAF prophylaxis protocol could significantly reduce costs, improve patient outcomes and increase the overall quality of care.

New Data Show that Patients with Left Main Disease Treated with PCI or CABG Have Similar Composite Outcomes at Five Years

sarah JonasResearch Results

Patients with left main coronary artery disease (LMCAD) typically have a poor prognosis due to the large amount of myocardium at risk. Revascularization with either percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG) has been shown to prolong survival in patients with left main disease compared with medical therapy alone. Three-year data from the large-scale randomized ECXEL trial found no significant difference in the composite rate of death, stroke or myocardial infarction (MI) between the two treatments, with a reduction in 30-day major adverse events with PCI. These results were first reported at TCT 2016 and published in NEJM.